Psychologists in Lake Geneva, WI Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Erin E Williams, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 146 E Geneva Sq, Lake Geneva, WI 53147 Phone: 877-666-7223 Fax: 262-249-7132 |
Dr. Sandra J Regan, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 146 E Geneva Sq, Lake Geneva, WI 53147 Phone: 262-249-4620 Fax: 262-249-7132 |
 Daniel M Christy Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 146 E Geneva Sq, Lake Geneva, WI 53147 Phone: 262-249-4620 |
Dr. Lisa Anne Pualani Sanchez-johnsen, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: N2251 Wilderland Dr, Lake Geneva, WI 53147 Phone: 262-729-2910 |
Frank J Elmudesi, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 420 Madison St, Lake Geneva, WI 53147 Phone: 262-374-0068 Fax: 251-847-3096 |
Dr. Cindy Jo Forster-fueredi, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1010 Geneva St, Lake Geneva, WI 53147 Phone: 815-761-0970 |
News Archive
Study identifies multipotent and unipotent stem cells that contribute to prostate postnatal development
Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.
Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds
Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ, a noninvasive early form of breast cancer.
Nanotechnology could boost stem cell transplantation research
Nanotechnology developed at Rutgers University-New Brunswick could boost research on stem cell transplantation, which may help people with Alzheimer's disease, Parkinson's disease, other neurodegenerative diseases and central nervous system injuries.
Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
› Verified 4 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Clinical Social Workers
Psychologists